F
Forte Biosciences, Inc. (FBRX)
NCM – Real vaqt narxi. Valyuta: USD
24.29
-1.71 (-6.58%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
24.29
-1.71 (-6.58%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Forte Biosciences, Inc. Qo'shma Shtatlarda klinik bosqichdagi biofarmatsevtika kompaniyasi sifatida faoliyat yuritadi. Kompaniyaning asosiy mahsuloti FB-102 hisoblanadi, bu turli autoimmün kasalliklar va autoimmün bilan bog'liq holatlar, masalan, çölyak kasalligi, vitiligо, alopetsiya areata va 1-toifa diabet uchun mo'ljallangan CD122 ga qarshi o'ziga xos monoklonal antitelar terapiyasidir. Forte Biosciences, Inc. shtab-kvartirasi Dallasda, Texasda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Barbara K. Finck M.D. | Acting Senior Medical Clinician & Director |
| Dr. Paul A. Wagner Ph.D. | CEO, President & Chairman |
| Mr. Antony A. Riley C.P.A. | Chief Financial Officer |
| Mr. Christopher Roenfeldt | Chief Operating Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-29 | ARS | d66937dars.pdf |
| 2026-04-01 | 8-K | d63145d8k.htm |
| 2026-03-31 | 10-K | fbrx-20251231.htm |
| 2025-11-14 | 10-Q | fbrx-20250930.htm |
| 2025-09-30 | S-8 | d83263ds8.htm |
| 2025-08-14 | 8-K | d939022d8k.htm |
| 2025-08-14 | 10-Q | fbrx-20250630.htm |
| 2025-06-25 | 8-K | d944948d8k.htm |
| 2025-06-23 | 8-K | d874957d8k.htm |
| 2025-05-30 | 8-K | d908206d8k.htm |